tiprankstipranks
Advertisement
Advertisement
Cyclopharm Director John Wigglesworth Steps Down, Retains Shareholding
PremiumCompany AnnouncementsCyclopharm Director John Wigglesworth Steps Down, Retains Shareholding
28d ago
Cyclopharm reshapes board as it accelerates Technegas push in U.S. market
Premium
Company Announcements
Cyclopharm reshapes board as it accelerates Technegas push in U.S. market
28d ago
Cyclopharm lodges updated ASX corporate governance statement for 2025
Premium
Company Announcements
Cyclopharm lodges updated ASX corporate governance statement for 2025
1M ago
Cyclopharm Director Increases Shareholding via Share Purchase Plan
PremiumCompany AnnouncementsCyclopharm Director Increases Shareholding via Share Purchase Plan
2M ago
Cyclopharm Director Increases Stake via Share Purchase Plan
Premium
Company Announcements
Cyclopharm Director Increases Stake via Share Purchase Plan
2M ago
Cyclopharm Director Increases Stake via Share Purchase Plan
Premium
Company Announcements
Cyclopharm Director Increases Stake via Share Purchase Plan
2M ago
Cyclopharm Raises $182,500 in Modest Share Purchase Plan Amid Tough Markets
PremiumCompany AnnouncementsCyclopharm Raises $182,500 in Modest Share Purchase Plan Amid Tough Markets
2M ago
Cyclopharm delays settlement of T2 placement shares to April 2026
Premium
Company Announcements
Cyclopharm delays settlement of T2 placement shares to April 2026
2M ago
Cyclopharm posts record revenue as U.S. Technegas sales surge but losses deepen
Premium
Company Announcements
Cyclopharm posts record revenue as U.S. Technegas sales surge but losses deepen
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100